Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 12;12(1):279.
doi: 10.1038/s41467-020-20542-0.

Mechanism of SARS-CoV-2 polymerase stalling by remdesivir

Goran Kokic  1 , Hauke S Hillen  1   2 , Dimitry Tegunov  1 , Christian Dienemann  1 , Florian Seitz  3 , Jana Schmitzova  1 , Lucas Farnung  1 , Aaron Siewert  3 , Claudia Höbartner  4 , Patrick Cramer  5
Affiliations

Mechanism of SARS-CoV-2 polymerase stalling by remdesivir

Goran Kokic et al. Nat Commun. .

Abstract

Remdesivir is the only FDA-approved drug for the treatment of COVID-19 patients. The active form of remdesivir acts as a nucleoside analog and inhibits the RNA-dependent RNA polymerase (RdRp) of coronaviruses including SARS-CoV-2. Remdesivir is incorporated by the RdRp into the growing RNA product and allows for addition of three more nucleotides before RNA synthesis stalls. Here we use synthetic RNA chemistry, biochemistry and cryo-electron microscopy to establish the molecular mechanism of remdesivir-induced RdRp stalling. We show that addition of the fourth nucleotide following remdesivir incorporation into the RNA product is impaired by a barrier to further RNA translocation. This translocation barrier causes retention of the RNA 3'-nucleotide in the substrate-binding site of the RdRp and interferes with entry of the next nucleoside triphosphate, thereby stalling RdRp. In the structure of the remdesivir-stalled state, the 3'-nucleotide of the RNA product is matched and located with the template base in the active center, and this may impair proofreading by the viral 3'-exonuclease. These mechanistic insights should facilitate the quest for improved antivirals that target coronavirus replication.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Remdesivir impairs RNA elongation by RdRp.
a Chemical structure of remdesivir triphosphate (RTP) showing the ribose 1ʹ cyano group. b RNA template-product duplex. The direction of RNA elongation is indicated. c Remdesivir-induced RdRp stalling. Replacing ATP with RTP leads to an elongation barrier after addition of three more nucleotides. The barrier can be overcome at higher NTP concentrations. The RNA 5ʹ-end contains a fluorescent label. Asterisk indicates 3ʹ-dGTP. Source data are provided as a Source Data file. d Quantification of the experiment in panel c after triplicate measurements. Standard deviations are shown. Source data are provided as a Source Data file.
Fig. 2
Fig. 2. Preparation of remdesivir-containing RNA.
a Scheme of the synthesis of 5ʹ-O-DMT-2ʹ-O-TBDMS-protected 3ʹ-cyanoethyl diisopropyl phosphoramidite (Rem-PA), which was used to synthesize RNA oligos with remdesivir monophosphate (RMP) at defined positions. b Analysis of RMP-containing RNA by denaturing HPLC confirms the presence of RMP. c Analysis of the RMP-containing RNA by LC-MS after digestion into mononucleosides confirms the presence of RMP. d Minimal RNA template-product scaffold with RMP (R) or AMP (A) in a synthesized RNA oligonucleotide product strand. e The presence of RMP in a synthesized RNA oligonucleotide inhibits RNA extension by RdRp on the minimal RNA scaffold (d). Source data are provided as a Source Data file.
Fig. 3
Fig. 3. Structural analysis of remdesivir-induced RdRp stalling.
a Position of RNA scaffolds 1–3 as observed in RdRp-RNA complex structures 1–3. Template and product strands are on the top and bottom, respectively. b Cryo-EM density of RNA in the active center of structures 1–3. The active site metal ion was modeled and is shown as a magenta sphere. c The C1ʹ-cyano group of the RMP ribose moiety (violet) is accommodated at position –3 (left), but would clash with the side chain of nsp12 residue serine-861 (red) at position –4 (right). Spheres indicate atomic van der Waals surfaces.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Hilgenfeld R, Peiris M. From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses. Antivir. Res. 2013;100:286–295. - PMC - PubMed
    1. Snijder EJ, Decroly E, Ziebuhr J. The nonstructural proteins directing coronavirus RNA synthesis and processing. Adv. Virus Res. 2016;96:59–126. - PMC - PubMed
    1. Posthuma CC, Te Velthuis AJW, Snijder EJ. Nidovirus RNA polymerases: complex enzymes handling exceptional RNA genomes. Virus Res. 2017;234:58–73. - PMC - PubMed
    1. Romano, M., Ruggiero, A., Squeglia, F., Maga, G. & Berisio, R. A Structural view of SARS-CoV-2 RNA replication machinery: RNA synthesis, proofreading and final capping. Cells9, 10.3390/cells9051267 (2020). - PMC - PubMed
    1. Jiang, Y., Yin, W. & Xu, H. E. RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19. Biochem. Biophys. Res. Commun. 10.1016/j.bbrc.2020.08.116 (2020). - PMC - PubMed

Publication types

MeSH terms